# The roles of folate, MTHFR genetics, vitamin B12 in pregnancy outcomes

**Authors:** Ruihua Yang, Guanghui Li

PMC · DOI: 10.3389/fnut.2026.1785263 · Frontiers in Nutrition · 2026-03-04

## TL;DR

This review explores how folate, MTHFR genetics, and vitamin B12 affect various pregnancy outcomes beyond neural tube defects, emphasizing the need for personalized nutrition strategies.

## Contribution

The paper consolidates evidence on how folate metabolism modifiers influence non-structural pregnancy outcomes and proposes a foundation for precision nutrition.

## Key findings

- Folic acid effects on pregnancy outcomes are influenced by timing, dose, and duration of supplementation.
- MTHFR genetic polymorphisms and vitamin B12 levels significantly modify folate's impact on pregnancy outcomes.
- There is a lack of established optimal folate thresholds to balance the prevention of different complications.

## Abstract

Folate is essential for fetal development, and periconceptional folic acid (FA) supplementation is well-established for preventing neural tube defects. However, evidence regarding its role in other pregnancy outcomes, such as gestational diabetes mellitus, hypertensive disorders of pregnancy, fetal growth, miscarriage, and preterm birth, remains inconsistent. Current knowledge indicates that the effects of FA are not uniform but significantly influenced by the timing, dose, and duration of supplementation, frequently exhibiting U-shaped or timing-dependent relationships. Furthermore, methylenetetrahydrofolate reductase (MTHFR) genetic polymorphisms and vitamin B12 levels are critical modifiers of folate metabolism and its association with pregnancy outcomes. Crucially, there is a lack of quantitative studies linking circulating folate levels to the risk of adverse outcomes, and no optimal threshold range has been established to balance the prevention of different complications. This review consolidates the existing evidence on the associations between FA supplementation, circulating folate levels, and non-structural pregnancy outcomes, while elucidating the modulating roles of MTHFR genetics and vitamin B12. Besides, it highlights possible underlying biological mechanism of hyperhomocysteinemia, alterations in DNA methylation, the presence of folate receptor antibody (FRAbs), and the direct anti-inflammatory effects of folate. This review aims to provide a foundation for a future precision nutrition strategy through individual physiological folate levels, MTHFR genetics, and vitamin B12 status.

## Linked entities

- **Genes:** MTHFR (methylenetetrahydrofolate reductase) [NCBI Gene 4524]
- **Chemicals:** folic acid (PubChem CID 135398658), folate (PubChem CID 135405876), vitamin B12 (PubChem CID 73415824), homocysteine (PubChem CID 778)
- **Diseases:** gestational diabetes mellitus (MONDO:0005406)

## Full-text entities

- **Genes:** MTHFR (methylenetetrahydrofolate reductase) [NCBI Gene 4524]
- **Diseases:** miscarriage (MESH:D000022), hyperhomocysteinemia (MESH:D020138), preterm birth (MESH:D047928), hypertensive disorders (MESH:D006973), inflammatory (MESH:D007249), gestational diabetes mellitus (MESH:D016640), pregnancy (MESH:D011254), neural tube defects (MESH:D009436)
- **Chemicals:** vitamin B12 (MESH:D014805), FA (MESH:D005492)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12995692/full.md

## References

140 references — full list in the complete paper: https://tomesphere.com/paper/PMC12995692/full.md

---
Source: https://tomesphere.com/paper/PMC12995692